Patent · US Active

Method for removal of viruses from blood by lectin affinity hemodialysis

US10022483B2 · kind B2 · utility

1Cited by
33References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 18, 2014
Grant dateJul 17, 2018
Priority date
Expiry dateApr 7, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P39/00
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.